Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.36%
1,096.72
+3.98
+0.36%
—1,092.741,095.951,103.321,094.72——
SIXC
Communications
SIXC
Communications
SIXC
-0.33%
611.32
-2.04
-0.33%
—613.36613.36613.36609.50——
SIXE
Energy
SIXE
Energy
SIXE
-0.45%
1,171.54
-5.25
-0.45%
—1,176.791,176.521,182.251,166.69——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.45%
1,747.63
-7.91
-0.45%
—1,755.541,759.231,766.301,746.04——
SIXM
Financials
SIXM
Financials
SIXM
-0.58%
631.49
-3.66
-0.58%
—635.15635.20636.89630.09——
SIXR
Staples
SIXR
Staples
SIXR
+0.23%
849.94
+1.93
+0.23%
—848.01852.52855.78849.58——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.09%
218.06
+0.20
+0.09%
—217.86217.86219.52217.86——
SIXT
Technology
SIXT
Technology
SIXT
+3.47%
3,536.03
+118.68
+3.47%
—3,417.353,452.773,536.033,450.39——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.91%
905.07
-8.29
-0.91%
—913.36915.10920.43904.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.86%
1,449.86
-12.52
-0.86%
—1,462.381,461.131,464.531,446.02——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.30%
2,430.47
+7.33
+0.30%
—2,423.142,428.712,448.692,424.63——
002773:SHE
Chengdu Kanghong Pharma Grp Co Ltd
CN¥24.23
-1.46%
(-0.36) 1D
May 8, 3:04:45 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002773...
Open
CN¥24.59
High
CN¥24.71
Low
CN¥24.10
Mkt. cap
22.66B
Avg. vol.
11.75M
Volume
7.87M
P/E ratio
20.96
52-wk high
CN¥47.37
52-wk low
CN¥24.10
EPS
CN¥1.16
Shares outstanding
921.33M
No. of employees
4K
News stories
From sources across the web
Profile
Chengdu Kanghong Pharmaceutical Group Co., Ltd. is a publicly traded pharmaceutical company based in the province of Sichuan, China. It was founded in 1996 and researches, develops, manufactures, and distributes medicines for ophthalmic, central nervous, digestive and endocrine systems. The company is listed on the Shenzhen stock exchange with a market capitalization at around $6 billion. As of May 2021, the company had 18 drugs on the market including Lumitin. Additional products include Songling xuemaikang capsules, Keluoxin capsules, Xinluona, Bolexin and Bosiqing, Yitaning, Shugan Jieyu, Danshu, and Yiqing. Kanghong also currently has 13 subsidiaries in China, Israel, and the United States. Wikipedia
About Chengdu Kanghong Pharma Grp Co Ltd
CEO-
Employees4.47K
FoundedOct 3, 1996
Headquarters-
SectorPharmaceutical industry
Websitecnkh.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.25B
1.17B
961.27M
1.05B
Cost of goods sold
122.11M
103.16M
116.91M
118.65M
Cost of revenue
122.11M
103.16M
116.91M
118.65M
Research and development expenses
120.31M
119.54M
198.94M
86.77M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
625.05M
595.28M
521.75M
478.88M
Operating expense
776.05M
697.02M
764.40M
582.81M
Total operating expenses
898.15M
800.18M
881.31M
701.46M
Operating income
356.77M
370.02M
79.96M
345.02M
Other non operating income
2.60M
-19.53M
19.27M
-1.04M
EBT including unusual items
389.66M
355.99M
147.66M
358.51M
EBT excluding unusual items
382.36M
364.66M
135.96M
356.60M
Income tax expense
64.42M
56.73M
23.28M
55.31M
Effective tax rate
16.53%
15.94%
15.77%
15.43%
Other operating expenses
30.17M
-17.83M
43.89M
16.62M
Net income
329.68M
303.21M
130.06M
307.48M
Net profit margin
26.27%
25.91%
13.53%
29.38%
Earnings per share
-
-
-
-
Interest and investment income
22.96M
14.20M
36.91M
12.63M
Interest expense
-
-
-
-
Net interest expenses
22.96M
14.20M
36.91M
12.63M
Depreciation and amortization charges
-
-
-
-
EBITDA
414.65M
427.31M
139.05M
404.11M
Gain or loss from assets sale
-3.47K
3.47K
-9.78K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer